Diseases, Conditions, Syndromes

A new target in the fight against TB

(Medical Xpress)—Researchers have identified a potential new route for attacking tuberculosis that may hold promise against drug-resistant strains of the disease and even dormant TB infections.

Diseases, Conditions, Syndromes

Scientists gain new understanding of latent tuberculosis

Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for 50 years, the disease still infects nearly 2.2 billion people worldwide ...

Diseases, Conditions, Syndromes

US urges shorter treatment for TB

US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.

Medical research

Scientists explain unique activity of TB drug pyrazinamide

Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood.

Diseases, Conditions, Syndromes

Pediatric tuberculosis in Canada: A guide for physicians

Although pediatric tuberculosis (TB) remains relatively uncommon in Canada, some populations—including Aboriginal communities—have a much higher burden of disease. As a result, Canada should focus on addressing the high ...

Medications

Vaccine targeting latent TB enters clinical testing

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...

page 5 from 7